Amneal Targets Migraine With 505(b)(2) Filing

Pursues Headache Market In US With Dihydroergotamine Autoinjector

Headache Migraine Pain
Amneal is targeting migraine and cluster headache • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Value Added Medicines

More from Products